Lung Neoplasms: all 7,333 studies

Page 7 of 74. Open to participants first (1,554), then studies with results posted, then the rest; newest registration first within each.

• SERS-Based Serum Molecular Spectral Detection of Invasive Lung CancerNot yet recruitingNCT06775015
• SERS-Based Serum Molecular Spectral Screening for Lung Cancer TypeNot yet recruitingNCT06775002
• Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung CancerEnrolling by invitationNCT06773156Phase 2
• SERS Sensor Based on CHA Reaction for EGFR Mutation Typing in Advanced Lung CancerNot yet recruitingNCT06772376
• SERS-Based Serum Molecular Spectral Screening for Hematogenous MetastasisNot yet recruitingNCT06772363
• Association Between RVT and Prognosis After Neoadjuvant Targeted Therapy in EGFR NSCLCRecruitingNCT06771960
• Predicting Symptom Trajectories After Thoracoscopic Lung Cancer Surgery Using an Interpretable Machine Learning ModelNot yet recruitingNCT06771947
• A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLCRecruitingNCT06769295Phase 2
• The Accuracy of Targeted Lymph Node Dissection of Non-small Cell Lung Cancer Patients According to Predictive ModelsNot yet recruitingNCT06768853Not applicable
• A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung CancerRecruitingNCT06768151Phase 1
• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLCRecruitingNCT06765109Phase 3
• FHND9041 Versus Afatinib for Non-small Cell Lung CancerEnrolling by invitationNCT06759857Phase 3
• Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung CancerRecruitingNCT06758700Phase 2
• This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.RecruitingNCT06758401Phase 3
• A Study on the Efficacy of Immunotherapy, the Occurrence and Severity of Adverse Reactions in Patients with Non-small Cell Lung Cancer in High-altitude AreasNot yet recruitingNCT06757114
• Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung CancerRecruitingNCT06755684Phase 2
• A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLCRecruitingNCT06754930Phase 1/2
• Aumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung CancerNot yet recruitingNCT06752408Phase 2
• Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary LesionsEnrolling by invitationNCT06752395Not applicable
• Disitamab Vedotin in Combination with Tislelizumab and Bevacizumab in a Phase II Clinical Study of Locally Advanced or Metastatic Non-small Cell Lung Cancer with HER2 Mutation/amplification/expressionRecruitingNCT06749860Phase 2
• Liposomal Irinotecan and Apatinib in ES-SCLCRecruitingNCT06749691Phase 2
• INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung CancerEnrolling by invitationNCT06747832Early Phase 1
• Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical StudyNot yet recruitingNCT06747169Phase 2
• ICARE-LCS QUERI Partnered Evaluation Initiative: Integrating Comprehensive Tobacco Treatment to Enhance Lung Cancer ScreeningNot yet recruitingNCT06745258
• Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung CancerRecruitingNCT06743308Not applicable
• Application of DCE-MRI Based on 4D FreeBreathing in Predicting the Efficacy of Immune and Targeted Therapy in Lung CancerRecruitingNCT06742021Not applicable
• The Diagnostic Value of Bronchoscopic Needle-based Confocal Laser Endomicroscopy (nCLE) As a Real-time Detection Tool for Diagnosing Peripheral Lung Cancer: a Multi-centre Randomised Controlled TrialNot yet recruitingNCT06739421Not applicable
• PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1Not yet recruitingNCT06738680
• Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung CancerRecruitingNCT06737107
• Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung CancerRecruitingNCT06734182Phase 2
• A Study Developing a Non-invasive Urine-based Proteomic Model for Early Lung Cancer Detection.RecruitingNCT06733311
• A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)RecruitingNCT06731907Phase 2
• Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent ImmunotherapyRecruitingNCT06731270Phase 2
• Sarcopenia and Cachexia in Patients With Lung CancerEnrolling by invitationNCT06730685
• Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung CancerRecruitingNCT06730503
• Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Centrally Located Early-stage Non-small Cell Lung CancerRecruitingNCT06730295Phase 2
• Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical StudyRecruitingNCT06728852Phase 2
• Cognitive Screening in Lung Cancer PatientsRecruitingNCT06727370
• Machine Learning for Predicting and Managing Quality of Life in Lung Cancer Immunotherapy PatientsNot yet recruitingNCT06725225Not applicable
• A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid TumorsNot yet recruitingNCT06724263Phase 2
• Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001)Not yet recruitingNCT06719336Phase 3
• A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in ChinaRecruitingNCT06718972
• Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLCRecruitingNCT06718309Phase 2
• The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic ProfilingRecruitingNCT06717295
• Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)RecruitingNCT06717243
• EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx PopulationsRecruitingNCT06716580Not applicable
• Prehabilitation for Patients Undergoing Lung Cancer SurgeryRecruitingNCT06716437Not applicable
• Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central LungRecruitingNCT06712745Early Phase 1
• Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung CancerRecruitingNCT06712355Phase 3
• Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)RecruitingNCT06712316Phase 2/3
• Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLCNot yet recruitingNCT06709274Not applicable
• A Master Trial Assessing the Technical Feasibility of First-In-Human Real-Time Image Guided Radiation Therapy MethodsNot yet recruitingNCT06708221Not applicable
• NSCLC Liquid Biopsies and Exhaled VOCRecruitingNCT06707519
• Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung CancerRecruitingNCT06706713Phase 2
• Cross-sectorial Rehabilitation of Patients with Lung CancerRecruitingNCT06705465Not applicable
• Value-Based Medicine (VBM) for Lung CancerRecruitingNCT06703866
• Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain MetastasesRecruitingNCT06702826Phase 2
• Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and CarboplatinRecruitingNCT06698965Phase 2
• The Regression Pattern of Primary Lesions in Lung Cancer After Definitive RadiotherapyRecruitingNCT06692972
• Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)RecruitingNCT06691776Not applicable
• A Single-Arm, Phase Ⅰb Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLCNot yet recruitingNCT06690671Phase 1/2
• DEPRECAP: Lung Cancer Screening Programme by LDCT for Patients With COPD or Emphysema.RecruitingNCT06690385
• Bronchoscopic Microwave Ablation of Lung Tissue in Surgical CandidatesRecruitingNCT06689488
• Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLCNot yet recruitingNCT06688656Phase 2
• Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation TherapyRecruitingNCT06688422Not applicable
• Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical TechniquesRecruitingNCT06687408
• Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung CancerRecruitingNCT06684418
• Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain MetastasesNot yet recruitingNCT06683703Phase 2
• Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung CancerNot yet recruitingNCT06682884Phase 2
• A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 ExpressionRecruitingNCT06682793Phase 1/2
• Transbroncheal Novel PDT Peripheral Lung Tumor Ablation With 5-ALANot yet recruitingNCT06679712Not applicable
• Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical MutationsRecruitingNCT06674343Phase 3
• A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical SurgeryRecruitingNCT06674252Not applicable
• Brodalumab in the Treatment of Immune-Related Adverse EventsRecruitingNCT06673329Phase 1
• Thoracic Surgery by the Medtronic Hugo™ Robotic SystemRecruitingNCT06669104
• A Phase 2 Clinical Study of Combination Therapy With ABSK043 and FirmonertinibRecruitingNCT06668103Phase 2
• First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+TrodelvyRecruitingNCT06667167Phase 2
• Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With ChemotherapyRecruitingNCT06667154Phase 2
• Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLCRecruitingNCT06663306Phase 1
• Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).RecruitingNCT06663098Phase 2
• Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer PatientsRecruitingNCT06659458
• Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung CancerRecruitingNCT06659042Phase 2
• Oxford Pleural Embolisation TrialRecruitingNCT06651658Not applicable
• SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC)Not yet recruitingNCT06646770Not applicable
• PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic MalignanciesRecruitingNCT06646471Phase 4
• PET-imaging of Two Vartumabs in Patients With Solid TumorsRecruitingNCT06645808Early Phase 1
• Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular CarcinomaRecruitingNCT06644430
• Vebreltinib for Neoadjuvant in MET-altered Stage IIIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)Not yet recruitingNCT06644313Phase 2
• Partial Pressure of Oxygen Control Method in Identification of Intersegmental PlaneRecruitingNCT06644066Not applicable
• A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung CancerNot yet recruitingNCT06643910Not applicable
• Lung Cancer and Aging: Improving Well-being for Older Adults With Lung CancerNot yet recruitingNCT06636721Not applicable
• Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cmRecruitingNCT06634979Not applicable
• Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC PatientsRecruitingNCT06634199
• Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) StudyRecruitingNCT06628102Not applicable
• Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases.RecruitingNCT06626178Not applicable
• Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsRecruitingNCT06625775Phase 1
• Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLCRecruitingNCT06623656Phase 2
• Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung CancerRecruitingNCT06622174Phase 1
• Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by BrigatinibRecruitingNCT06620835Phase 2
• Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical TrialNot yet recruitingNCT06620822Phase 2

← Lung Neoplasms overview